TrademarkDir
VIRAMUNE XR
LIVE

Serial Number

77939784

Owner

BOEHRINGER INGELHEIM PHARMACUETICALS, INC.

Attorney

Scott J. Major

First Use Date

Apr 7, 2011

Filing Date

Feb 19, 2010

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

VIRAMUNE XR Trademark

Serial Number: 77939784 • Registration: 4168351

VIRAMUNE XR is a trademark filed by BOEHRINGER INGELHEIM PHARMACUETICALS, INC. on February 19, 2010. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

BOEHRINGER INGELHEIM PHARMACUETICALS, INC. (4 trademarks)

900 RIDGEBURY ROAD
RIDGEFIELD, CT 06877

Entity Type: 03

Trademark Details

Filing Date

February 19, 2010

Registration Date

July 3, 2012

First Use Anywhere

April 7, 2011

First Use in Commerce

April 7, 2011

Published for Opposition

July 20, 2010

Goods & Services

Antivirals; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of HIV-1 infection; therapeutic pharmaceutical for the treatment of HIV-1 infection

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jul 21, 2022 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jul 21, 2022 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jul 21, 2022 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 21, 2022 APRE
TEAS SECTION 8 & 9 RECEIVED
Feb 8, 2022 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jul 3, 2021 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Aug 28, 2017 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Aug 28, 2017 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 28, 2017 APRE
TEAS SECTION 8 & 15 RECEIVED
Jul 21, 2017 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 3, 2017 REM1
REGISTERED-PRINCIPAL REGISTER
Jul 3, 2012 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 1, 2012 SUNA
LAW OFFICE REGISTRATION REVIEW COMPLETED
May 31, 2012 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 29, 2012 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 8, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 8, 2012 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 18, 2012 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 9, 2011 GNFN
FINAL REFUSAL E-MAILED
Dec 9, 2011 GNFR
SU - FINAL REFUSAL - WRITTEN
Dec 9, 2011 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 18, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 17, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 17, 2011 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 30, 2011 GNRN
NON-FINAL ACTION E-MAILED
Oct 30, 2011 GNRT
SU - NON-FINAL ACTION - WRITTEN
Oct 30, 2011 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 3, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 3, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 3, 2011 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 15, 2011 GNRN
NON-FINAL ACTION E-MAILED
Sep 15, 2011 GNRT
SU - NON-FINAL ACTION - WRITTEN
Sep 15, 2011 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Aug 10, 2011 SUPC
USE AMENDMENT FILED
Aug 5, 2011 IUAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 5, 2011 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 5, 2011 REAP
TEAS STATEMENT OF USE RECEIVED
Aug 5, 2011 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 6, 2010 EXRA
SOU EXTENSION 1 GRANTED
Oct 5, 2010 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 5, 2010 AITU
SOU EXTENSION 1 FILED
Sep 14, 2010 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 14, 2010 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 14, 2010 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 20, 2010 NPUB
PUBLISHED FOR OPPOSITION
Jul 20, 2010 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 12, 2010 PREV
ASSIGNED TO LIE
Jun 10, 2010 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 26, 2010 CNSA
ASSIGNED TO EXAMINER
May 24, 2010 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 24, 2010 NWOS
NEW APPLICATION ENTERED
Feb 23, 2010 NWAP

Related Trademarks

More from this Owner

SUPPLIFEM

SUPPLIFEM

SUPPLIFEM

SUPPLIFEM

SUPPLIFEM

SUPPLIFEM

THERA-PRO

THERA-PRO

THERA-PRO

THERA-PRO

VIRAMUNE

VIRAMUNE